181 related articles for article (PubMed ID: 10506209)
1. Physical and functional interaction between p53 and the Werner's syndrome protein.
Blander G; Kipnis J; Leal JF; Yu CE; Schellenberg GD; Oren M
J Biol Chem; 1999 Oct; 274(41):29463-9. PubMed ID: 10506209
[TBL] [Abstract][Full Text] [Related]
2. p53 Modulates the exonuclease activity of Werner syndrome protein.
Brosh RM; Karmakar P; Sommers JA; Yang Q; Wang XW; Spillare EA; Harris CC; Bohr VA
J Biol Chem; 2001 Sep; 276(37):35093-102. PubMed ID: 11427532
[TBL] [Abstract][Full Text] [Related]
3. p53-mediated apoptosis is attenuated in Werner syndrome cells.
Spillare EA; Robles AI; Wang XW; Shen JC; Yu CE; Schellenberg GD; Harris CC
Genes Dev; 1999 Jun; 13(11):1355-60. PubMed ID: 10364153
[TBL] [Abstract][Full Text] [Related]
4. The Werner syndrome gene: the molecular basis of RecQ helicase-deficiency diseases.
Shen JC; Loeb LA
Trends Genet; 2000 May; 16(5):213-20. PubMed ID: 10782115
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of the interaction between WRN, the helicase/exonuclease defective in progeroid Werner's syndrome, and an essential replication factor, PCNA.
Rodríguez-López AM; Jackson DA; Nehlin JO; Iborra F; Warren AV; Cox LS
Mech Ageing Dev; 2003 Feb; 124(2):167-74. PubMed ID: 12633936
[TBL] [Abstract][Full Text] [Related]
6. The Werner's Syndrome RecQ helicase/exonuclease at the nexus of cancer and aging.
Chun SG; Shaeffer DS; Bryant-Greenwood PK
Hawaii Med J; 2011 Mar; 70(3):52-5. PubMed ID: 21365542
[TBL] [Abstract][Full Text] [Related]
7. The Werner syndrome protein contributes to induction of p53 by DNA damage.
Blander G; Zalle N; Leal JF; Bar-Or RL; Yu CE; Oren M
FASEB J; 2000 Nov; 14(14):2138-40. PubMed ID: 11023999
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer.
Agrelo R; Cheng WH; Setien F; Ropero S; Espada J; Fraga MF; Herranz M; Paz MF; Sanchez-Cespedes M; Artiga MJ; Guerrero D; Castells A; von Kobbe C; Bohr VA; Esteller M
Proc Natl Acad Sci U S A; 2006 Jun; 103(23):8822-7. PubMed ID: 16723399
[TBL] [Abstract][Full Text] [Related]
9. Tumorigenic effect of nonfunctional p53 or p21 in mice mutant in the Werner syndrome helicase.
Lebel M; Cardiff RD; Leder P
Cancer Res; 2001 Mar; 61(5):1816-9. PubMed ID: 11280729
[TBL] [Abstract][Full Text] [Related]
10. Covalent modification of the Werner's syndrome gene product with the ubiquitin-related protein, SUMO-1.
Kawabe Y; Seki M; Seki T; Wang WS; Imamura O; Furuichi Y; Saitoh H; Enomoto T
J Biol Chem; 2000 Jul; 275(28):20963-6. PubMed ID: 10806190
[TBL] [Abstract][Full Text] [Related]
11. DNA damage-induced translocation of the Werner helicase is regulated by acetylation.
Blander G; Zalle N; Daniely Y; Taplick J; Gray MD; Oren M
J Biol Chem; 2002 Dec; 277(52):50934-40. PubMed ID: 12384494
[TBL] [Abstract][Full Text] [Related]
12. Asymmetry of DNA replication fork progression in Werner's syndrome.
Rodríguez-López AM; Jackson DA; Iborra F; Cox LS
Aging Cell; 2002 Oct; 1(1):30-9. PubMed ID: 12882351
[TBL] [Abstract][Full Text] [Related]
13. p53 modulates RPA-dependent and RPA-independent WRN helicase activity.
Sommers JA; Sharma S; Doherty KM; Karmakar P; Yang Q; Kenny MK; Harris CC; Brosh RM
Cancer Res; 2005 Feb; 65(4):1223-33. PubMed ID: 15735006
[TBL] [Abstract][Full Text] [Related]
14. The Werner syndrome. A model for the study of human aging.
Nehlin JO; Skovgaard GL; Bohr VA
Ann N Y Acad Sci; 2000 Jun; 908():167-79. PubMed ID: 10911957
[TBL] [Abstract][Full Text] [Related]
15. Identification and biochemical characterization of a Werner's syndrome protein complex with Ku70/80 and poly(ADP-ribose) polymerase-1.
Li B; Navarro S; Kasahara N; Comai L
J Biol Chem; 2004 Apr; 279(14):13659-67. PubMed ID: 14734561
[TBL] [Abstract][Full Text] [Related]
16. Requirements for the nucleolytic processing of DNA ends by the Werner syndrome protein-Ku70/80 complex.
Li B; Comai L
J Biol Chem; 2001 Mar; 276(13):9896-902. PubMed ID: 11152456
[TBL] [Abstract][Full Text] [Related]
17. Werner's syndrome protein (WRN) migrates Holliday junctions and co-localizes with RPA upon replication arrest.
Constantinou A; Tarsounas M; Karow JK; Brosh RM; Bohr VA; Hickson ID; West SC
EMBO Rep; 2000 Jul; 1(1):80-4. PubMed ID: 11256630
[TBL] [Abstract][Full Text] [Related]
18. LMNA mutations in atypical Werner's syndrome.
Chen L; Lee L; Kudlow BA; Dos Santos HG; Sletvold O; Shafeghati Y; Botha EG; Garg A; Hanson NB; Martin GM; Mian IS; Kennedy BK; Oshima J
Lancet; 2003 Aug; 362(9382):440-5. PubMed ID: 12927431
[TBL] [Abstract][Full Text] [Related]
19. Werner's syndrome protein is phosphorylated in an ATR/ATM-dependent manner following replication arrest and DNA damage induced during the S phase of the cell cycle.
Pichierri P; Rosselli F; Franchitto A
Oncogene; 2003 Mar; 22(10):1491-500. PubMed ID: 12629512
[TBL] [Abstract][Full Text] [Related]
20. Formation of a nuclear complex containing the p53 tumor suppressor, YB-1, and the Werner syndrome gene product in cells treated with UV light.
Guay D; Gaudreault I; Massip L; Lebel M
Int J Biochem Cell Biol; 2006; 38(8):1300-13. PubMed ID: 16584908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]